Teleflex Incorporated Stock News

Related Stocks: V , XOM , DVN , RY , FB , PBR , CRM , ALC , ZI , MA , MPWR , SNAP , BABA , HUM , BAC , LRCX , VALE , NTES , AEO , LEVI , X , NUE , TFX ,

This Respiratory Therapy Equipment market report depicts industrial analysis, growth factors, driving factors and recent market trends, which greatly benefit to the newly entering key players in the industry. This market report is very important for them as it covers

Related Stocks: ICLR , TMO , GLOB , HTGC , OMCL , TECH , MRVI , DOCS , MRNA , AVTR , STLD , CPRI , BRK.B , SMG , TKR , PNR , TFX , GM ,

Bouvel Investment Partners LLC grew its position in Teleflex Incorporated (NYSE:TFX) by 2.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,992 shares of the medical technology company’s stock after acquiring an additional 155 shares during the period. Bouvel Investment Partners LLC’s […]

Canada Varicose Vein Treatment Devices Market: Overview As per the study published in NCBI or National Centre for Biotechnology Information, over 3.7 million people in Canada are living with varicose veins. This has considerably heightened the need for effective and enhanced

Investors are optimistic about Teleflex (TFX) owing to better-than-anticipated results in the third quarter and strength in the Vascular business.

Global Mucosal Atomization Devices Industry: with growing significant CAGR during Forecast 2020-2027 Latest Research Report on Mucosal Atomization Devices Market which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), and Consumption Analysis Understand the influence of COVID-19 on the Mucosal Atomization Devices Market with our analysts monitoring the situation across the globe. []

Teleflex Incorporated (NYSE:TFX) VP Cameron P. Hicks sold 3,600 shares of the stock in a transaction dated Wednesday, November 10th. The shares were sold at an average price of $350.00, for a total value of $1,260,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC []

Teleflex's (TFX) CEO Liam Kelly on Q3 2021 Results - Earnings Call Transcript

Teleflex (TFX) delivered earnings and revenue surprises of 15.84% and 0.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Teleflex (NYSE:TFX) is set to give its latest quarterly earnings report on Thursday, 2021-10-28. Here's what investors need to know before the announcement.

WAYNE, Pa., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m.

Late-Breaking Data Presentation Reveals How UroLift PUL's Post-Operative Events Compare With Other Minimally Invasive Procedures and Traditional Surgery for the Treatment of BPH Late-Breaking Data Pre

Teleflex's (TFX) new real-world data outcomes together with product launches demonstrate the importance of UroLift System for most BPH patients.

New real-world data findings along with new product evolutions demonstrate why the UroLift ® System is the right solution for most BPH patients